John Aaskov

The paper models dengue transmission from humans to mosquitoes and shows that administering defective virus reduces viral load and inhibits transmission.

This paper models the interaction between dengue virus and transmissible interfering particles to assess their potential as an antiviral agent, showing that 80% effectiveness requires a high dose to reduce infection severity.

The paper evaluates the effect of defective interfering particles on dengue virus within-host dynamics using population of models to estimate their therapeutic potential.